Test Drive Our New Site! We have some improvements in the works that we're excited for you to experience. Click here to try our new, faster, mobile friendly beta site. We will be maintaining our current version of the site thru the end of 2024, so you can switch back as our improvements continue.
Legislation Quick Search
06/14/2024 04:38 AM
Pennsylvania House of Representatives
Home / House Co-Sponsorship Memoranda

House Co-Sponsorship Memoranda

Subscribe to PaLegis Notifications

Subscribe to receive notifications of new Co-Sponsorship Memos circulated

By Member | By Date | Keyword Search

House of Representatives
Session of 2023 - 2024 Regular Session


Posted: September 27, 2023 11:22 AM
From: Representative Tina M. Davis
To: All House members
Subject: Resolution Designating October 9, 2023 as "PANDAS Awareness Day" in Pennsylvania
In the near future, I will be introducing a resolution designating October 9, 2023, as “PANDAS Awareness Day” in Pennsylvania.

PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections) occurs when a strep infection triggers a misdirected immune response, resulting in inflammation on a child’s brain. The child quickly begins to exhibit life changing symptoms such as OCD, anxiety, tics, personality changes, a decline in math and handwriting abilities, sensory sensitivities, and restrictive eating. The PANDAS Network estimates that PANDAS affects as many as 1 in 200 children.

PANDAS is frequently misdiagnosed and mistreated due to the lack of awareness and conflicting interpretations and subjective observation in the medical community. The National Institute of Mental Health (NIMH) has dedicated resources to research and broaden awareness of the disorder, but PANDAS still remains a subject of much debate and controversy.

Please join me in recognizing October 9, 2023, as “PANDAS Awareness Day” to bring awareness of this new and unfamiliar disorder to the public and medical community and encourage more research to determine the cause of PANDAS and more effective treatments for children suffering from the disorder.

Introduced as HR239